| 종목코드 | 종목명 | 수량 | 평가금액(원) | 비중(%) |
|---|---|---|---|---|
| LLY US EQUITY | Eli Lilly & Co | 57 | 77,788,577 | 15.19 |
| ARWR US EQUITY | Arrowhead Pharmaceuticals Inc | 215 | 23,537,236 | 4.60 |
| JNJ US EQUITY | Johnson & Johnson | 68 | 22,770,078 | 4.45 |
| TEVA US EQUITY | Teva Pharmaceutical Industries Ltd | 484 | 22,378,620 | 4.37 |
| NVS US EQUITY | Novartis AG | 101 | 22,036,272 | 4.30 |
| BIIB US EQUITY | Biogen Inc | 77 | 21,675,012 | 4.23 |
| NTRA US EQUITY | Natera Inc | 70 | 21,540,552 | 4.21 |
| NVO US EQUITY | Novo Nordisk A/S | 356 | 20,641,289 | 4.03 |
| GILD US EQUITY | Gilead Sciences Inc | 104 | 20,469,789 | 4.00 |
| MRNA US EQUITY | Moderna Inc | 236 | 19,433,089 | 3.79 |
| REGN US EQUITY | Regeneron Pharmaceuticals Inc | 17 | 18,796,644 | 3.67 |
| TMO US EQUITY | Thermo Fisher Scientific Inc | 24 | 18,268,905 | 3.57 |
| MRK US EQUITY | Merck & Co Inc | 105 | 17,554,959 | 3.43 |
| 226950 | 올릭스 | 101 | 17,473,000 | 3.41 |
| TERN US EQUITY | Terns Pharmaceuticals Inc | 214 | 16,746,792 | 3.27 |
| RVTY US EQUITY | Revvity Inc | 118 | 16,476,184 | 3.22 |
| IONS US EQUITY | Ionis Pharmaceuticals Inc | 146 | 16,180,191 | 3.16 |
| ALNY US EQUITY | Alnylam Pharmaceuticals Inc | 33 | 15,178,976 | 2.96 |
| EXEL US EQUITY | Exelixis Inc | 218 | 15,125,897 | 2.95 |
| MEDP US EQUITY | Medpace Holdings Inc | 20 | 15,060,585 | 2.94 |
| GPCR US EQUITY | Structure Therapeutics Inc | 205 | 14,117,632 | 2.76 |
| AMGN US EQUITY | Amgen Inc | 25 | 12,807,688 | 2.50 |
| ABBV US EQUITY | AbbVie Inc | 43 | 12,768,441 | 2.49 |
| GSK US EQUITY | GSK PLC | 118 | 9,734,020 | 1.90 |
| 현금 | 9,288,707 | 9,288,707 | 1.81 | |
| ICLR US EQUITY | ICON PLC | 54 | 9,231,398 | 1.80 |
| 174900 | 앱클론 | 104 | 5,184,400 | 1.01 |
| 구분 | 1주 | 1개월 | 3개월 | 6개월 | 1년 | 3년 | 연초 이후 | 상장 이후 |
|---|---|---|---|---|---|---|---|---|
| 기준가 | -1.11 | -0.47 | -9.99 | 11.28 | 25.39 | - | -7.63 | 3.27 |
| 비교지수 | -0.87 | 0.51 | -6.20 | 9.97 | 27.64 | - | -1.17 | 9.79 |
| 초과성과 | -0.24 | -0.98 | -3.79 | 1.31 | -2.25 | - | -6.46 | -6.52 |
| 일자 | 기준가격(원) | 시장가격(원) | 과표기준가(원) | ||
|---|---|---|---|---|---|
| 기준가격(원) | 등락률(%) | 종가(원) | 등락률(%) | ||
| 2026.04.24 | 10,121.63 | -1.21 | 10,060.00 | -0.89 | 0.00 |
| 2026.04.23 | 10,245.30 | 1.04 | 10,150.00 | 0 | 9,316.37 |
| 2026.04.22 | 10,140.00 | -0.39 | 10,150.00 | -0.2 | 9,228.61 |
| 2026.04.21 | 10,180.07 | -1.51 | 10,170.00 | -0.78 | 9,270.45 |
| 2026.04.20 | 10,336.36 | 0.75 | 10,250.00 | 0.05 | 9,393.00 |
| 2026.04.17 | 10,259.30 | -0.97 | 10,245.00 | -0.92 | 9,317.46 |
| 2026.04.16 | 10,360.16 | 0.1 | 10,340.00 | 0.34 | 9,394.90 |
| 2026.04.15 | 10,350.15 | 0.98 | 10,305.00 | 0.78 | 9,410.03 |
| 2026.04.14 | 10,250.10 | -0.07 | 10,225.00 | 0.05 | 9,321.97 |
| 2026.04.13 | 10,256.80 | -0.9 | 10,220.00 | -0.87 | 9,325.24 |
| 2026.04.10 | 10,349.73 | 0.07 | 10,310.00 | 0.29 | 9,415.82 |
| 2026.04.09 | 10,342.68 | 2.68 | 10,280.00 | 1.23 | 9,410.97 |
| 2026.04.08 | 10,073.09 | -1.89 | 10,155.00 | -0.64 | 9,132.67 |
| 2026.04.07 | 10,267.36 | -0.8 | 10,220.00 | -1.21 | 9,339.08 |
| 2026.04.06 | 10,350.29 | -0.12 | 10,345.00 | -0.77 | 9,422.96 |
| 2026.04.03 | 10,362.33 | -1.66 | 10,425.00 | 0.05 | 9,416.61 |
| 2026.04.02 | 10,536.83 | 1.25 | 10,420.00 | -0.33 | 9,570.10 |
| 2026.04.01 | 10,406.72 | 1.04 | 10,455.00 | 1.36 | 9,345.36 |
| 2026.03.31 | 10,300.02 | -0.49 | 10,315.00 | 0.44 | 9,221.58 |
| 2026.03.30 | 10,351.13 | -1.68 | 10,270.00 | -2.1 | 9,074.37 |
| 2026.03.27 | 10,527.68 | -0.52 | 10,490.00 | 0.24 | 9,260.94 |
| 2026.03.26 | 10,582.95 | 2.76 | 10,465.00 | 2.15 | 9,283.46 |
| 2026.03.25 | 10,298.94 | 1.08 | 10,245.00 | 1.04 | 9,048.57 |
| 운용 | AP/LP | 수탁 | 사무수탁 | 총보수(연%) |
|---|---|---|---|---|
| 0.69% | 0.04% | 0.04% | 0.03% | 총 0.80% |